339 related articles for article (PubMed ID: 28842849)
1. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
2. Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine - temporal relation to bleeding and hormone withdrawal: a prospective diary-based study.
Merki-Feld GS; Caveng N; Speiermann G; MacGregor EA
J Headache Pain; 2020 Jun; 21(1):81. PubMed ID: 32580694
[TBL] [Abstract][Full Text] [Related]
3. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
[TBL] [Abstract][Full Text] [Related]
4. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
Coffee AL; Sulak PJ; Hill AJ; Hansen DJ; Kuehl TJ; Clark JW
J Womens Health (Larchmt); 2014 Apr; 23(4):310-7. PubMed ID: 24450487
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
6. Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study.
De Icco R; Cucinella L; De Paoli I; Martella S; Sances G; Bitetto V; Sandrini G; Nappi G; Tassorelli C; Nappi RE
J Headache Pain; 2016 Dec; 17(1):70. PubMed ID: 27488685
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of migraine with onset prior to or during start of combined hormonal contraception: a prospective cohort study.
Merki-Feld GS; Sandor PS; Nappi RE; Pohl H; Schankin C
Acta Neurol Belg; 2022 Apr; 122(2):401-409. PubMed ID: 33928470
[TBL] [Abstract][Full Text] [Related]
8. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes JL; Smith T; Diamond M; Ames MH
Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
[TBL] [Abstract][Full Text] [Related]
9. Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
van Casteren DS; Verhagen IE; van der Arend BWH; van Zwet EW; MaassenVanDenBrink A; Terwindt GM
Neurology; 2021 Oct; 97(17):e1661-e1671. PubMed ID: 34493613
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
11. Menstrual Migraines: Diagnosis, Evidence, and Treatment.
Olson AK; Hansen KA
S D Med; 2021 Dec; 74(12):570-575. PubMed ID: 35015948
[TBL] [Abstract][Full Text] [Related]
12. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study.
Newman L; Mannix LK; Landy S; Silberstein S; Lipton RB; Putnam DG; Watson C; Jöbsis M; Batenhorst A; O'Quinn S
Headache; 2001 Mar; 41(3):248-56. PubMed ID: 11264684
[TBL] [Abstract][Full Text] [Related]
13. Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?
Merki-Feld GS; Imthurn B; Dubey R; Sándor PS; Gantenbein AR
J Obstet Gynaecol; 2017 Apr; 37(3):338-341. PubMed ID: 28129717
[TBL] [Abstract][Full Text] [Related]
14. Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?
Tiranini L; Cucinella L; Martella S; Bosoni D; Martini E; Nappi RE
Expert Rev Neurother; 2023 Apr; 23(4):377-388. PubMed ID: 37038655
[TBL] [Abstract][Full Text] [Related]
15. Menstrual migraine: a review of prophylactic therapies.
Martin VT
Curr Pain Headache Rep; 2004 Jun; 8(3):229-37. PubMed ID: 15115643
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of menstrual migraine.
MacGregor EA
Drugs; 2010 Oct; 70(14):1799-818. PubMed ID: 20836574
[TBL] [Abstract][Full Text] [Related]
17. Headache, menstruation and combined oral contraceptives: a diary study in 184 women with migraine.
Lieba-Samal D; Wöber C; Frantal S; Brannath W; Schmidt K; Schrolnberger C; Wöber-Bingöl C;
Eur J Pain; 2011 Sep; 15(8):852-7. PubMed ID: 21402485
[TBL] [Abstract][Full Text] [Related]
18. The inconvenience due to women's monthly bleeding (ISY) survey: a study of premenstrual symptoms among 5728 women in Europe.
Lete I; Häusler G; Pintiaux A; Jamin C; Nappi RE; Fiala C; Chabbert-Buffet N; Lobo P
Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):354-359. PubMed ID: 29157023
[TBL] [Abstract][Full Text] [Related]
19. Burden of migraine related to menses: results from the AMPP study.
Pavlović JM; Stewart WF; Bruce CA; Gorman JA; Sun H; Buse DC; Lipton RB
J Headache Pain; 2015 Mar; 16():24. PubMed ID: 25902814
[TBL] [Abstract][Full Text] [Related]
20. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse.
Calhoun A; Ford S
Headache; 2008 Sep; 48(8):1186-93. PubMed ID: 18819179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
